Find Academic Supervisors

• Radiation Oncology
• Medical Physics
• Treatment Planning Techniques
• +5 more

Dr. Sotirios Stathakis is Chief of Physics at the Mary Bird Perkins Cancer Center (2023–Present) and Associate Director of the Medical Physics Division at the University of Texas Health Science Center San Antonio (2017–2022). He holds an Adjunct Professor position at Louisiana State University's Department of Physics and Astronomy (2023–Present). His expertise lies in radiation oncology and medical physics, with a focus on patient-specific quality assurance, dose verification, and advanced treatment techniques like adaptive radiation therapy and SBRT. Education: Ph.D., Medical Physics, University of Patras (2005) M.S., Medical Physics, University of Aberdeen (1997) B.S., Physics (minor in Mathematics and Computer Science), University of Waterloo (1995) Research Interests: Patient-specific quality assurance Daily dose verification Treatment planning techniques Adaptive radiation therapy Stereotactic body radiation therapy (SBRT) Automation and workflow optimization in radiation oncology Publications: Over 20 peer-reviewed articles since 2020, focusing on topics like Monte Carlo simulations, AI-driven beam analysis, and AAPM task group recommendations for IMRT verification. Key themes include improving dose accuracy, equipment validation, and clinical implementation of advanced radiation technologies. Grants & Awards: Not explicitly listed in provided text. Labs/Teams: Collaborates with institutions like Fox Chase Cancer Center, South Texas Veterans Health Administration, and LSU on medical physics research and clinical applications.

• Medical Physics
• Radiation Oncology
• Therapeutic Radiology
• +7 more

Huixiao Chen is an Assistant Professor and Clinical Medical Physicist II in the Department of Therapeutic Radiology at Yale School of Medicine. She holds a primary appointment in Therapeutic Radiology and is actively engaged in clinical and research activities related to radiation oncology physics. Assistant Professor, Department of Therapeutic Radiology, Yale School of Medicine Clinical Medical Physicist II, Therapeutic Radiology Education: Resident, Yale University (2016) Postdoctoral Fellow, Harvard University (2013) Postdoctoral Fellow, Virginia Commonwealth University (2011) PhD, University of Heidelberg, Germany (2010) MS, Zhejiang University, China (1998) BS, Zhejiang University, China (1995) Huixiao Chen's research centers on medical physics in radiation oncology, with a focus on treatment planning optimization, dosimetry, and image-guided radiotherapy. Her work includes the development and evaluation of advanced radiotherapy techniques such as VMAT and SBRT, with applications in spine, lung, and prostate cancers. She has contributed to improving the accuracy of dose calculations using Monte Carlo methods and has explored the impact of patient motion on treatment delivery. Her research also extends to the design of clinical devices to support safe and effective radiotherapy for diverse patient populations. Her recent publications demonstrate a consistent focus on enhancing the precision and efficiency of radiotherapy. Key themes include multicriteria optimization in treatment planning, dosimetric validation of radiochromic films, and the development of supportive devices for image-guided radiotherapy. These works reflect a strong commitment to advancing clinical medical physics through both computational and engineering innovations. Scientific Contributions: Characterization of GafchromicTM EBT4 film for clinical dosimetry Design of a small-footprint couch-top support for heavy patients in IGRT Application of multicriteria optimization in VMAT planning for spine and prostate cancers Comparison of Monte Carlo vs. pencil beam algorithms in lung SBRT Analysis of diaphragm motion effects on spine SBRT Huixiao Chen has collaborated with researchers such as Emily Draeger and Zhe Jay Chen on various projects. While no formal students or grants are listed, her role as a clinical medical physicist and faculty member suggests active mentorship and potential involvement in funded research. She is a key contributor to the medical physics team at Yale, ensuring high standards in treatment planning and delivery.

Amar U. KishanView profile

Professor

• Translational Research
• Clinical Outcomes Research
• Advanced Radiation Technologies
• +5 more

Amar U. Kishan, MD , a tenure Professor at the David Geffen School of Medicine, UCLA , serves as Executive Vice Chair for the Department of Radiation Oncology and as Chief of the Genitourinary Service since 2019. His clinical expertise focuses on radiation treatment of prostate and bladder cancers , with pioneering work in stereotactic body radiation therapy (SBRT) and image-guided radiotherapy . Dr. Kishan graduated magna cum laude from Harvard Medical School after dual BA degrees at UC Berkeley in Molecular and Cell Biology and Public Health, followed by residency at UCLA and internship at Scripps Mercy Hospital . Education : Harvard Medical School (MD, 2012), UC Berkeley (BA in Molecular/Cell Biology & Public Health) Awards : Leonard Tow Humanism in Medicine (2021), UCLA Exceptional Physician (2024), Super Doctors® Rising Stars (2020-2024) Dr. Kishan leads translational research connecting radiation oncology with genitourinary cancer biology. His 310+ publications in journals like JAMA , Lancet Oncology , and European Urology emphasize radiation technology innovations , including MRI-guided SBRT and adaptive radiation therapy. Key trials he spearheads include ILLUSION (CT-guided SBRT) and HEATWAVE (apalutamide + SBRT). Major funding sources include National Institutes of Health , Department of Defense , and Prostate Cancer Foundation . His work has redefined prostate cancer treatment paradigms , demonstrating that high-dose radiation can match surgery in aggression cases, while multi-modal approaches improve survival rates. Dr. Kishan also contributes to re-irradiation protocols and radioresistance proteogenomics , advancing precision oncology. Key Grants : NIH, DoD, PCF, ASTRO Clinical Trials : ILLUSION, HEATWAVE, PET imaging-based radiation targeting

• Radiation Therapy
• Medical Physics
• Oncology
• +3 more

Ping Xia, PhD, is a Physician Scientist affiliated with Cleveland Clinic's Department of Radiation Oncology. She holds primary appointments at the Cleveland Clinic Main Campus and specializes in advanced radiation therapy techniques. Her expertise includes image-guided radiation therapy (IGRT) and intensity-modulated radiation therapy (IMRT), focusing on precision oncology treatments. Dr. Xia received her undergraduate and graduate degrees in Physics from Beijing Normal University (1983, 1986) and completed her medical physics education at the University of Virginia (1993). She has been actively involved in clinical research, particularly in optimizing radiation therapy protocols to improve patient outcomes. Her current roles emphasize translational research and clinical applications of advanced radiation technologies. No industry financial relationships were reported as of April 2024.

• Radiation Oncology
• Therapeutic Radiology
• Cancer Treatment
• +8 more

Dr. Patrick Oh serves as an Assistant Professor of Therapeutic Radiology at Yale School of Medicine, practicing as a radiation oncologist at Yale Cancer Center and Smilow Cancer Hospital. He specializes in treating thoracic and genitourinary cancers, as well as hematologic, cutaneous, and metastatic malignancies with an emphasis on individualized, holistic patient care to optimize both disease outcomes and quality of life. His educational background includes: BS from Duke University MD from Stony Brook University School of Medicine Preliminary Medicine Intern at NYU Langone Hospital-Long Island Resident Physician in Radiation Oncology at Yale New Haven Hospital (served as Chief Resident) Gamma Knife Cranial Radiosurgery Certification from Cleveland Clinic Dr. Oh's research focuses on reducing radiation-induced toxicities, particularly cardiopulmonary effects, and expanding the role of radiation therapy across various cancer types. His clinical expertise encompasses advanced radiotherapy techniques including stereotactic body radiation therapy (SBRT), intensity-modulated radiation therapy (IMRT/VMAT), and image-guided radiation therapy (IGRT). Professional recognition includes: RSNA Roentgen Resident Research Award (awarded June 7, 2025) Dr. Oh is dedicated to medical education, actively mentoring residents and medical students with emphasis on communication skills and patient-centered care. He maintains active professional memberships including the American Society for Therapeutic Radiology (2021-present), where he serves on the Board of the Korean American Society for Therapeutic Radiation Oncology (2024-present), and the American Society of Clinical Oncology (2018-present). He treats both adult and pediatric patients and accepts new appointments through Yale Medicine.

• Nonlinear Programming
• Optimization Methods
• Radiation Therapy Optimization
• +2 more

Anders Forsgren is a Professor of Optimization and Systems Theory at the Department of Mathematics, KTH Royal Institute of Technology since 2003. His research focuses on nonlinear programming, particularly Newton-type methods for smooth optimization, with applications in radiation therapy, cell biology, and telecommunications. PhD in Optimization and Systems Theory (KTH, 1990) MS in Operations Research (Stanford, 1987) MSc in Engineering Physics (KTH, 1985) Research Interests: Anders develops methods for constrained optimization and applies them to intensity-modulated radiation therapy, metabolic networks, and wireless communication systems. His work bridges algorithmic innovation with real-world clinical and engineering challenges. Recent Publications: Focus on robust optimization for radiation therapy under uncertainty, quasi-Newton methods, and applications in medical physics. His 2025 papers address interplay-robust optimization and scenario positioning in proton therapy. Scientific Leadership: Co-chair, 8th SIAM Conference on Optimization (2005) Editorial board member, Computational Optimization and Applications (since 1998) Member, Mathematical Optimization Society and SIAM Mentorship: Supervises PhD students in optimization and systems theory, with former advisees working on radiation therapy robustness, metabolic modeling, and network design.

Elizabeth M. NicholsView profile

Professor

• Breast Cancer Treatment
• Radiation Therapy
• Proton Therapy
• +3 more

Elizabeth M. Nichols is a Professor in the Department of Radiation Oncology at the University of Maryland School of Medicine. She serves as Clinical Director and Vice Chair of Clinical Operations at the University of Maryland Medical Center and Maryland Proton Treatment Center. MD from University of Maryland School of Medicine (2008) Residency in Radiation Oncology at University of Maryland (2013) BS in Science from Duke University (2004) Dr. Nichols specializes in radiation therapy for breast and gynecologic malignancies, with specific research focus on: GammaPod TM treatment for early-stage breast cancers Pre-operative partial breast irradiation Proton therapy applications in breast cancer Radiation therapy for uterine carcinosarcoma Her publications between 2013-2016 demonstrate sustained expertise in optimizing radiation therapy protocols for breast and gynecologic cancers, including comparative analyses of radiation techniques and dose optimization studies. Dr. Nichols actively contributes to medical education through: Participation in the Core Mentoring Program Teaching Introduction to Clinical Medicine I for first-year medical students

Sameer NathView profile

Associate Professor

• Radiation Oncology
• Prostate Cancer
• Lung Cancer
• +3 more

Sameer Nath, MD, is an Associate Professor in the Department of Radiation Oncology at the University of Colorado Anschutz Medical Campus School of Medicine. He holds leadership roles as Vice Chair of Clinical Affairs, Clinical Practice Director at Anschutz Medical Campus, and Medical Director of Radiation Oncology at Highlands Ranch Hospital. Dr. Nath is board-certified in Radiation Oncology and practices at UCHealth Radiation Oncology and Rocky Mountain Gamma Knife Center. MD: University of California, San Diego School of Medicine (2010) Internship: University of California, San Diego (2011) Residency: Yale-New Haven Medical Center, Chief Resident in Radiation Oncology (2015) His research focuses on radiation therapy applications for prostate and lung cancers, brain metastases management, and immunotherapy-radiation combinations. He has pioneered work in stereotactic body radiation therapy (SBRT), tumor hypoxia, radiation pneumonitis prevention, and medical imaging innovations for treatment planning. Recent publications examine oligoprogressive prostate cancer management, radiation oncology nurse education, and deep learning applications in patient positioning. Dr. Nath's 15 most recent publications (2024-2017) demonstrate expertise in prostate cancer (4 articles), lung cancer (4 articles), brain metastases (4 articles), and medical imaging/education (3 articles). Key research themes include SBRT optimization, immunotherapy response monitoring, and radiation toxicity management. American Society of Radiation Oncology (ASTRO) Member Practice locations: UCHealth Radiation Oncology - Anschutz Medical Campus (Aurora, CO) and Rocky Mountain Gamma Knife Center - Anschutz Medical Campus (Aurora, CO) Hospital affiliations: UCHealth Highlands Ranch Hospital and University of Colorado Hospital

• Radiation Oncology
• Particle Therapy
• Medical Physics
• +4 more

Professor J. Debus is a distinguished academic in Radiation Oncology at Heidelberg University's Medical Faculty, with extensive research focused on particle therapy, medical physics, and cancer treatment optimization. His work spans clinical trials, radiobiology, and technical innovations in radiation delivery systems. Primary Affiliation: German Cancer Research Center (DKFZ), Heidelberg Research Focus: Particle therapy, radiation oncology, medical physics Key Collaborations: Mein S., Liew H., Tessonnier T., and other leading researchers in radiation oncology Professor Debus' research interests center on advancing particle therapy techniques including proton, carbon ion, and emerging modalities like helium and oxygen ion therapy. His work addresses critical challenges in radiation oncology such as normal tissue sparing, hypoxia-induced radioresistance, and precision treatment delivery. He has made significant contributions to understanding the biological effects of different radiation types and optimizing treatment protocols for various cancer types including head and neck cancers, brain metastases, and prostate cancer. His recent publications demonstrate leadership in clinical trials (GUARD, ESTRON, PROBASE) and technical innovations in radiation delivery systems, particularly in the emerging field of FLASH radiotherapy and ultra-high dose rate treatments. Professor Debus has published extensively on treatment planning optimization, radiation-induced biological effects, and imaging techniques for precise radiation delivery. Leading clinical trials in particle therapy Developing novel techniques for normal tissue protection Advancing understanding of radiation biology across different modalities Professor Debus has secured significant research funding for his work in radiation oncology and particle therapy. His research has contributed to clinical implementation of advanced treatment techniques at the Heidelberg Ion-Beam Therapy Center (HIT), one of the world's leading facilities for particle therapy. He supervises numerous doctoral students and postdoctoral researchers in the radiation oncology field. His laboratory and research team focus on translational research bridging basic radiobiology with clinical applications, with particular emphasis on optimizing treatment protocols for challenging tumor types and improving patient outcomes through precision radiation therapy.

Matthew J. FerrisView profile

Associate Professor

• Head and Neck Cancer Radiation Therapy
• Thoracic Cancer Radiation Therapy
• Skin Cancer Radiation Therapy
• +6 more

Matthew J. Ferris is an Associate Professor in the Department of Radiation Oncology at the University of Maryland and serves as Medical Director of the Maryland Proton Treatment Center (MPTC) with additional administrative roles as Billing & Compliance Director. His clinical expertise spans head and neck, thoracic, and skin cancers using advanced radiation modalities including proton therapy, VMAT, and stereotactic techniques. Dr. Ferris completed his education and training as follows: Undergraduate: Loyola University Maryland, 2010, Biology (minors in Business and English), summa cum laude Medical School: University of Maryland School of Medicine, 2014, cum laude Internship: Emory University, 2015 Residency: Radiation Oncology, Emory University, 2019 (Chief Resident) His research centers on optimizing radiation techniques to maximize tumor control while minimizing toxicities, with particular focus on cardiac-sparing methods for thoracic cancers, radiation dose effects on the heart and CNS in head/neck cancers, and proton therapy applications for skin malignancies. He actively develops clinical trials to advance precision radiation oncology and improve patient-reported outcomes through meticulous treatment planning. Recent publications (2018-2024) reveal consistent investigation into proton therapy's advantages over conventional modalities, especially for reducing dose to critical structures like the heart and brainstem. Key themes include comparative toxicity outcomes for parotid gland cancers, cardiac substructure sparing in lung cancer, and proton therapy applications for early glottic cancer - demonstrating his commitment to evidence-based refinement of radiation techniques. Dr. Ferris maintains active interest in clinical trial development and enrollment, though specific grant details aren't provided. As Medical Director of MPTC, he leads a multidisciplinary team integrating surgeons and medical oncologists to deliver coordinated cancer care, emphasizing precision throughout the radiation treatment process.

• Head and Neck Cancer
• Prostate Cancer
• Radiation Oncology
• +8 more

Dr. Julie Kang, MD, PhD is an Assistant Professor of Therapeutic Radiology at Yale School of Medicine and a board-certified radiation oncologist specializing in head and neck, prostate, bladder, and skin cancers. She practices at Smilow Cancer Hospital Care Center at Trumbull and is affiliated with Yale Cancer Center and Yale Medicine. Her educational background includes a BS from Yale University (2002), PhD from University of Southern California (2008), MD from University of Southern California (2010), and residency at UCLA (2015). Dr. Kang's research focuses on optimizing cancer treatment outcomes while minimizing toxicity through advanced radiation techniques including intensity-modulated radiation therapy, image-guided radiation therapy, stereotactic body radiation therapy, and adaptive radiation therapy. She has extensive experience conducting clinical trials utilizing immunotherapy and personalized medicine approaches for head and neck and prostate cancers. Her work emphasizes analyzing factors that influence cancer outcomes to enhance healthcare quality, with particular interest in addressing cancer disparities and reducing barriers to care. Analysis of Dr. Kang's recent publications (2022-2025) reveals a strong focus on treatment de-escalation strategies for HPV-associated oropharyngeal cancer, radiation dosing optimization for head and neck malignancies, and innovative applications of artificial intelligence in cancer care. Her research spans clinical trials, retrospective analyses, and systematic reviews addressing critical questions in radiation oncology with emphasis on improving patient outcomes while reducing treatment-related toxicity. Kaiser Permanente Everyday Hero Award Recipient (July 7, 2017) Kaiser Permanente Physician Merit Award (July 11, 2016) Dr. Kang is actively involved in clinical trials and cooperative groups, with a focus on mentoring the next generation of medical professionals in research related to head and neck and prostate cancers. Her clinical approach is deeply informed by personal experience as "the daughter of a cancer patient," emphasizing compassion, patient education, and personalized treatment planning. She is dedicated to not only delivering the highest standards of care but also raising them through continuous research and innovation in radiation oncology. As part of Yale's Therapeutic Radiology department, Dr. Kang contributes to a comprehensive cancer care program that includes state-of-the-art facilities such as the Yale Gamma Knife Center and Smilow Cancer Hospital, working within multidisciplinary teams to provide integrated cancer care across multiple locations including Hamden, Greenwich, and Lawrence and Memorial Cancer Center.

Andrew JirasekView profile

Professor

• Medical Physics
• Radiation Oncology Physics
• Raman Spectroscopy
• +3 more

Andrew Jirasek is a Professor at the Irving K. Barber Faculty of Science , University of British Columbia Okanagan , and serves as the Associate Dean for Graduate and Postdoctoral Training . He leads the Analytics in Medical Sciences (AiMS) Institute with a focus on Medical Physics and Radiation Oncology Physics , particularly utilizing Raman spectroscopy and 3D radiation dosimetry for cancer treatment verification. PhD from University of British Columbia His research involves developing polymer gel dosimeters for 3D radiation dose verification in complex therapies like volumetric modulated arc therapy (VMAT) , collaborating across physics, oncology, and engineering . He also investigates optical technologies to monitor biological responses during radiotherapy using Raman spectroscopy with machine learning for data analysis. Recent publications highlight advancements in 3D gel dosimetry , Raman spectroscopy for metabolic profiling , and iterative image reconstruction algorithms . His work spans dosimeter technology development , radiation therapy quality assurance , and clinical applicability studies for novel treatment verification methods.

• Exercise Oncology
• Cancer Rehabilitation
• Tumor Biology
• +5 more

Professor Rob Newton is a leading academic at Edith Cowan University (ECU) as the Professor of Exercise Medicine and founder of the Exercise Medicine Research Institute . He holds concurrent appointments as Vice-Chancellor Professorial Research Fellow in 2020 and has dedicated his career to integrating exercise as neoadjuvant, adjuvant, and rehabilitative therapy for cancer patients. His research spans exercise oncology, tumor biology, body composition, and quality of life in cancer care. He earned a Doctor of Science (DSc, 2021) PhD in Human Movement Studies (1998) Master of Human Movement Studies (1986) Bachelor of Human Movement Studies (Hons, 1986) from the University of Queensland and Southern Cross University. His recent work focuses on exercise-induced myokines , resistance training modalities , and exercise’s impact on cancer progression , with trends observed in breast, prostate, and ovarian cancers . Many studies employ systematic reviews, meta-analyses, and randomized controlled trials to evaluate exercise prescriptions. Scientific Awards : Career Achievement Award (2018) - Cancer Council WA Western Australia Premier’s Scientist of the Year (2019) With a Scopus h-index of 90 and over $45M in research funding , Newton leads interdisciplinary collaborations across oncology, sports science, and clinical exercise physiology . His lab has pioneered exercise medicine protocols for cancer patients, including the ERADICATE trial for prostate cancer and EXPAN trial for pancreatic cancer.

Peter B. SchiffView profile

Professor

• Radiation Oncology
• Stereotactic Body Radiotherapy (SBRT)
• Immunotherapy
• +4 more

Peter B. Schiff, MD, PhD is a Professor and Vice Chair in the Department of Radiation Oncology at NYU Grossman School of Medicine since 2009. He specializes in radiation oncology for lung, gynecologic, and other malignancies, emphasizing precision treatments like SBRT and IMRT. His clinical expertise includes non-small cell lung carcinoma, cervical/uterine cancers, and prostate cancer risk categorization. Education: MD from Albert Einstein College of Medicine (1984) PhD from Albert Einstein College of Medicine (1980) Residency in Radiation Oncology at Memorial Sloan-Kettering Cancer Center (1988) Research Interests: Focuses on stereotactic body radiotherapy (SBRT) for lung cancer, immunotherapy-radiation combinations, and IMRT/chemotherapy for gynecologic cancers. Active in clinical trials for prostate cancer treatment optimization and radiation dosimetry standards. Awards: Castle Connolly Top Doctor designation for over 15 years Clinical Trials: Leads trials on prostate cancer de-intensification strategies, novel therapies like MOMA-313, and perirectal spacing hydrogel systems in prostate radiotherapy.

Christian Rønn HansenView profile

Associate Professor

• Radiation Therapy
• Head and Neck Cancer
• Treatment Planning
• +7 more

Christian Rønn Hansen is an Associate Professor at the Department of Clinical Research, University of Southern Denmark , specializing in radiation therapy and oncology. His work spans head and neck cancer, prostate cancer, and glioma treatment planning, with a focus on advanced radiation techniques like VMAT, IMRT, and hypofractionation. Academic Affiliation : Department of Clinical Research, University of Southern Denmark Research Collaborations : KI (Karolinska Institute), OUH (Odense University Hospital), Danish Head and Neck Cancer Group (DAHANCA) Research Interests : Christian's research integrates artificial intelligence with magnetic resonance imaging for treatment adaptation, clinical trial quality assurance for radiation therapy, and pattern of failure analysis in head and neck cancer. His work also addresses thromboembolic risk in glioma patients and proton therapy applications for grade 1–3 gliomas. Scientific Contributions : His recent publications include systematic reviews on loco-regional failure patterns in head and neck cancer (2025), national data solutions for radiation oncology (2025), and AI-driven prostate volume analysis in hypo-fractionated radiotherapy (2025). He contributed to the 2023 ACTA ONCOLOGICA AWARD-winning work and leads discussions on international radiotherapy quality assurance standards. Scientific Awards : ACTA ONCOLOGICA AWARD (2023)